Country: United Kingdom
Language: English
Source: VMD (Veterinary Medicines Directorate)
Halofuginone
Livisto Int'l S.L.
QP51AX08
Halofuginone
Oral solution
POM-V - Prescription Only Medicine – Veterinarian
Cattle
Antiprotozoal
Authorized
2020-11-19
Revised: March 2022 AN: 02270/2021 & 02271/2021 Page 1 of 6 SUMMARY OF PRODUCT CHARACTERISTICS 1. NAME OF THE VETERINARY MEDICINAL PRODUCT Cryptisel 0.5 mg/ml oral solution for calves 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Halofuginone 0.50 mg Equivalent to 0.6086 mg of Halofuginone lactate EXCIPIENTS: Benzoic acid (E 210) 1.00 mg Tartrazine (E 102) 0.03 mg For the full list of excipients, see section 6.1 3. PHARMACEUTICAL FORM Oral solution. Clear yellow solution. 4. CLINICAL PARTICULARS 4.1 TARGET SPECIES Cattle (newborn calves). 4.2 INDICATIONS FOR USE, SPECIFYING THE TARGET SPECIES • Prevention of diarrhoea due to diagnosed _Cryptosporidium parvum_, in farms with history of cryptosporidiosis. Administration should start in the first 24 to 48 hours of age. • Reduction of diarrhoea due to diagnosed _Cryptosporidium parvum_. Administration should start within 24 hours after the onset of diarrhoea. In both cases, the reduction of oocysts excretion has been demonstrated. Revised: March 2022 AN: 02270/2021 & 02271/2021 Page 2 of 6 4.3 CONTRAINDICATIONS Do not use on an empty stomach. Do not use in cases of diarrhoea established for more than 24 hours and in weak animals. Do not use in cases of hypersensitivity to the active substance or to any of the excipients. 4.4 SPECIAL WARNINGS FOR EACH TARGET SPECIES None. 4.5 SPECIAL PRECAUTIONS FOR USE Special precautions for use in animals Administer after colostrum feeding, or after milk or milk replacer feeding only, using an appropriate device for oral administration. For treatment of anorexic calves, the veterinary medicinal product should be administered in half a litre of an electrolyte solution. The animals should receive enough colostrum according to good breeding practice. Special precautions to be taken by the person administering the veterinary medicinal product to animals - People with known hypersensitivity to the active substance or any of the excipients should administer the veterinary medicinal product with cauti Read the complete document